nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—CYP2C9—brain cancer	0.594	1	CbGaD
Meloxicam—PTGS2—Etoposide—brain cancer	0.0554	0.232	CbGbCtD
Meloxicam—CYP3A4—Temozolomide—brain cancer	0.0533	0.223	CbGbCtD
Meloxicam—PTGS1—Etoposide—brain cancer	0.0468	0.196	CbGbCtD
Meloxicam—CYP3A4—Lomustine—brain cancer	0.0453	0.19	CbGbCtD
Meloxicam—CYP2C8—Etoposide—brain cancer	0.027	0.113	CbGbCtD
Meloxicam—CYP3A4—Etoposide—brain cancer	0.011	0.0459	CbGbCtD
Meloxicam—Lornoxicam—CYP2C9—brain cancer	0.00241	0.409	CrCbGaD
Meloxicam—Tenoxicam—CYP2C9—brain cancer	0.00215	0.365	CrCbGaD
Meloxicam—Piroxicam—CYP2C9—brain cancer	0.00133	0.225	CrCbGaD
Meloxicam—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00129	0.0658	CbGpPWpGaD
Meloxicam—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00116	0.0591	CbGpPWpGaD
Meloxicam—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00109	0.0554	CbGpPWpGaD
Meloxicam—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00106	0.0538	CbGpPWpGaD
Meloxicam—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.000899	0.0458	CbGpPWpGaD
Meloxicam—PTGS2—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.000862	0.0439	CbGpPWpGaD
Meloxicam—ABCC4—Ectoderm Differentiation—TSC22D1—brain cancer	0.000791	0.0404	CbGpPWpGaD
Meloxicam—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000752	0.0384	CbGpPWpGaD
Meloxicam—PTGS2—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000597	0.0305	CbGpPWpGaD
Meloxicam—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000557	0.0284	CbGpPWpGaD
Meloxicam—PTGS1—ganglion—brain cancer	0.000556	0.0534	CbGeAlD
Meloxicam—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000536	0.0273	CbGpPWpGaD
Meloxicam—PGD—telencephalon—brain cancer	0.000512	0.0492	CbGeAlD
Meloxicam—PTGS1—endothelium—brain cancer	0.000479	0.046	CbGeAlD
Meloxicam—PTGS2—endothelium—brain cancer	0.000458	0.044	CbGeAlD
Meloxicam—PTGS1—blood vessel—brain cancer	0.000442	0.0424	CbGeAlD
Meloxicam—PGD—gonad—brain cancer	0.000427	0.041	CbGeAlD
Meloxicam—PTGS2—blood vessel—brain cancer	0.000423	0.0406	CbGeAlD
Meloxicam—PGD—pituitary gland—brain cancer	0.000417	0.04	CbGeAlD
Meloxicam—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000414	0.0211	CbGpPWpGaD
Meloxicam—PGD—medulla oblongata—brain cancer	0.000402	0.0386	CbGeAlD
Meloxicam—PGD—midbrain—brain cancer	0.000368	0.0353	CbGeAlD
Meloxicam—PGD—spinal cord—brain cancer	0.000359	0.0345	CbGeAlD
Meloxicam—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000329	0.0168	CbGpPWpGaD
Meloxicam—PGD—endocrine gland—brain cancer	0.000323	0.031	CbGeAlD
Meloxicam—PGD—head—brain cancer	0.000319	0.0306	CbGeAlD
Meloxicam—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000318	0.00241	CcSEcCtD
Meloxicam—Insomnia—Procarbazine—brain cancer	0.000315	0.0024	CcSEcCtD
Meloxicam—Paraesthesia—Procarbazine—brain cancer	0.000313	0.00238	CcSEcCtD
Meloxicam—Hepatobiliary disease—Temozolomide—brain cancer	0.000312	0.00237	CcSEcCtD
Meloxicam—Sinusitis—Temozolomide—brain cancer	0.00031	0.00236	CcSEcCtD
Meloxicam—Somnolence—Procarbazine—brain cancer	0.00031	0.00235	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000309	0.00235	CcSEcCtD
Meloxicam—Haemoglobin—Carmustine—brain cancer	0.000308	0.00234	CcSEcCtD
Meloxicam—Haemorrhage—Carmustine—brain cancer	0.000307	0.00233	CcSEcCtD
Meloxicam—Ill-defined disorder—Hydroxyurea—brain cancer	0.000307	0.00233	CcSEcCtD
Meloxicam—Anaemia—Hydroxyurea—brain cancer	0.000305	0.00232	CcSEcCtD
Meloxicam—Decreased appetite—Procarbazine—brain cancer	0.000303	0.0023	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Etoposide—brain cancer	0.000303	0.0023	CcSEcCtD
Meloxicam—Oedema peripheral—Carmustine—brain cancer	0.000302	0.0023	CcSEcCtD
Meloxicam—Connective tissue disorder—Carmustine—brain cancer	0.000302	0.00229	CcSEcCtD
Meloxicam—Fatigue—Procarbazine—brain cancer	0.0003	0.00228	CcSEcCtD
Meloxicam—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000299	0.0152	CbGpPWpGaD
Meloxicam—Haemoglobin—Temozolomide—brain cancer	0.000298	0.00227	CcSEcCtD
Meloxicam—Malaise—Hydroxyurea—brain cancer	0.000298	0.00226	CcSEcCtD
Meloxicam—Constipation—Procarbazine—brain cancer	0.000298	0.00226	CcSEcCtD
Meloxicam—Pain—Procarbazine—brain cancer	0.000298	0.00226	CcSEcCtD
Meloxicam—Hepatitis—Temozolomide—brain cancer	0.000297	0.00225	CcSEcCtD
Meloxicam—Haemorrhage—Temozolomide—brain cancer	0.000297	0.00225	CcSEcCtD
Meloxicam—Leukopenia—Hydroxyurea—brain cancer	0.000296	0.00225	CcSEcCtD
Meloxicam—Visual impairment—Carmustine—brain cancer	0.000296	0.00225	CcSEcCtD
Meloxicam—Pharyngitis—Temozolomide—brain cancer	0.000294	0.00224	CcSEcCtD
Meloxicam—Urinary tract disorder—Temozolomide—brain cancer	0.000293	0.00223	CcSEcCtD
Meloxicam—Oedema peripheral—Temozolomide—brain cancer	0.000292	0.00222	CcSEcCtD
Meloxicam—Bronchospasm—Etoposide—brain cancer	0.000292	0.00222	CcSEcCtD
Meloxicam—Connective tissue disorder—Temozolomide—brain cancer	0.000291	0.00221	CcSEcCtD
Meloxicam—PGD—central nervous system—brain cancer	0.000291	0.0279	CbGeAlD
Meloxicam—Urethral disorder—Temozolomide—brain cancer	0.000291	0.00221	CcSEcCtD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00029	0.0148	CbGpPWpGaD
Meloxicam—Sweating increased—Etoposide—brain cancer	0.000289	0.00219	CcSEcCtD
Meloxicam—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000288	0.0147	CbGpPWpGaD
Meloxicam—Feeling abnormal—Procarbazine—brain cancer	0.000287	0.00218	CcSEcCtD
Meloxicam—Eye disorder—Carmustine—brain cancer	0.000287	0.00218	CcSEcCtD
Meloxicam—Convulsion—Hydroxyurea—brain cancer	0.000286	0.00218	CcSEcCtD
Meloxicam—Visual impairment—Temozolomide—brain cancer	0.000286	0.00217	CcSEcCtD
Meloxicam—Gastrointestinal pain—Procarbazine—brain cancer	0.000285	0.00217	CcSEcCtD
Meloxicam—Flushing—Carmustine—brain cancer	0.000285	0.00216	CcSEcCtD
Meloxicam—PGD—cerebellum—brain cancer	0.000285	0.0273	CbGeAlD
Meloxicam—Pancytopenia—Etoposide—brain cancer	0.000282	0.00214	CcSEcCtD
Meloxicam—Erythema multiforme—Temozolomide—brain cancer	0.00028	0.00213	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000279	0.00212	CcSEcCtD
Meloxicam—Discomfort—Hydroxyurea—brain cancer	0.000278	0.00211	CcSEcCtD
Meloxicam—Eye disorder—Temozolomide—brain cancer	0.000277	0.00211	CcSEcCtD
Meloxicam—Urticaria—Procarbazine—brain cancer	0.000277	0.0021	CcSEcCtD
Meloxicam—Tinnitus—Temozolomide—brain cancer	0.000277	0.0021	CcSEcCtD
Meloxicam—Abdominal pain—Procarbazine—brain cancer	0.000276	0.00209	CcSEcCtD
Meloxicam—Body temperature increased—Procarbazine—brain cancer	0.000276	0.00209	CcSEcCtD
Meloxicam—Cardiac disorder—Temozolomide—brain cancer	0.000275	0.00209	CcSEcCtD
Meloxicam—Flushing—Temozolomide—brain cancer	0.000275	0.00209	CcSEcCtD
Meloxicam—Arrhythmia—Carmustine—brain cancer	0.000274	0.00208	CcSEcCtD
Meloxicam—Alopecia—Carmustine—brain cancer	0.000271	0.00206	CcSEcCtD
Meloxicam—Oedema—Hydroxyurea—brain cancer	0.00027	0.00205	CcSEcCtD
Meloxicam—Angiopathy—Temozolomide—brain cancer	0.000269	0.00204	CcSEcCtD
Meloxicam—Mental disorder—Carmustine—brain cancer	0.000269	0.00204	CcSEcCtD
Meloxicam—Infection—Hydroxyurea—brain cancer	0.000268	0.00204	CcSEcCtD
Meloxicam—Immune system disorder—Temozolomide—brain cancer	0.000268	0.00204	CcSEcCtD
Meloxicam—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000268	0.0136	CbGpPWpGaD
Meloxicam—Mediastinal disorder—Temozolomide—brain cancer	0.000267	0.00203	CcSEcCtD
Meloxicam—Malnutrition—Carmustine—brain cancer	0.000267	0.00203	CcSEcCtD
Meloxicam—Erythema—Carmustine—brain cancer	0.000267	0.00203	CcSEcCtD
Meloxicam—Nervous system disorder—Hydroxyurea—brain cancer	0.000265	0.00201	CcSEcCtD
Meloxicam—Infestation NOS—Etoposide—brain cancer	0.000264	0.00201	CcSEcCtD
Meloxicam—Infestation—Etoposide—brain cancer	0.000264	0.00201	CcSEcCtD
Meloxicam—Thrombocytopenia—Hydroxyurea—brain cancer	0.000264	0.00201	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000262	0.00199	CcSEcCtD
Meloxicam—Alopecia—Temozolomide—brain cancer	0.000262	0.00199	CcSEcCtD
Meloxicam—Skin disorder—Hydroxyurea—brain cancer	0.000262	0.00199	CcSEcCtD
Meloxicam—Acute coronary syndrome—Etoposide—brain cancer	0.000261	0.00198	CcSEcCtD
Meloxicam—Renal failure—Etoposide—brain cancer	0.00026	0.00197	CcSEcCtD
Meloxicam—Mental disorder—Temozolomide—brain cancer	0.00026	0.00197	CcSEcCtD
Meloxicam—Myocardial infarction—Etoposide—brain cancer	0.000259	0.00197	CcSEcCtD
Meloxicam—Back pain—Carmustine—brain cancer	0.000258	0.00196	CcSEcCtD
Meloxicam—Erythema—Temozolomide—brain cancer	0.000258	0.00196	CcSEcCtD
Meloxicam—Malnutrition—Temozolomide—brain cancer	0.000258	0.00196	CcSEcCtD
Meloxicam—Stomatitis—Etoposide—brain cancer	0.000258	0.00196	CcSEcCtD
Meloxicam—Jaundice—Etoposide—brain cancer	0.000258	0.00196	CcSEcCtD
Meloxicam—Hypersensitivity—Procarbazine—brain cancer	0.000257	0.00195	CcSEcCtD
Meloxicam—Dysgeusia—Temozolomide—brain cancer	0.000253	0.00192	CcSEcCtD
Meloxicam—Vision blurred—Carmustine—brain cancer	0.000252	0.00191	CcSEcCtD
Meloxicam—Tremor—Carmustine—brain cancer	0.00025	0.0019	CcSEcCtD
Meloxicam—Asthenia—Procarbazine—brain cancer	0.00025	0.0019	CcSEcCtD
Meloxicam—Hepatobiliary disease—Etoposide—brain cancer	0.00025	0.0019	CcSEcCtD
Meloxicam—Back pain—Temozolomide—brain cancer	0.00025	0.0019	CcSEcCtD
Meloxicam—Anaemia—Carmustine—brain cancer	0.000247	0.00188	CcSEcCtD
Meloxicam—Agranulocytosis—Etoposide—brain cancer	0.000247	0.00187	CcSEcCtD
Meloxicam—Pruritus—Procarbazine—brain cancer	0.000247	0.00187	CcSEcCtD
Meloxicam—Vision blurred—Temozolomide—brain cancer	0.000243	0.00185	CcSEcCtD
Meloxicam—Tremor—Temozolomide—brain cancer	0.000242	0.00184	CcSEcCtD
Meloxicam—Dyspnoea—Hydroxyurea—brain cancer	0.00024	0.00183	CcSEcCtD
Meloxicam—Somnolence—Hydroxyurea—brain cancer	0.00024	0.00182	CcSEcCtD
Meloxicam—Ill-defined disorder—Temozolomide—brain cancer	0.00024	0.00182	CcSEcCtD
Meloxicam—Leukopenia—Carmustine—brain cancer	0.000239	0.00182	CcSEcCtD
Meloxicam—Anaemia—Temozolomide—brain cancer	0.000239	0.00181	CcSEcCtD
Meloxicam—Diarrhoea—Procarbazine—brain cancer	0.000238	0.00181	CcSEcCtD
Meloxicam—Dyspepsia—Hydroxyurea—brain cancer	0.000237	0.0018	CcSEcCtD
Meloxicam—Angioedema—Temozolomide—brain cancer	0.000236	0.00179	CcSEcCtD
Meloxicam—Decreased appetite—Hydroxyurea—brain cancer	0.000234	0.00178	CcSEcCtD
Meloxicam—Urinary tract disorder—Etoposide—brain cancer	0.000234	0.00178	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000233	0.00177	CcSEcCtD
Meloxicam—Malaise—Temozolomide—brain cancer	0.000233	0.00177	CcSEcCtD
Meloxicam—Urethral disorder—Etoposide—brain cancer	0.000233	0.00177	CcSEcCtD
Meloxicam—Fatigue—Hydroxyurea—brain cancer	0.000233	0.00177	CcSEcCtD
Meloxicam—Vertigo—Temozolomide—brain cancer	0.000232	0.00176	CcSEcCtD
Meloxicam—Convulsion—Carmustine—brain cancer	0.000231	0.00176	CcSEcCtD
Meloxicam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000231	0.0118	CbGpPWpGaD
Meloxicam—Leukopenia—Temozolomide—brain cancer	0.000231	0.00176	CcSEcCtD
Meloxicam—PGD—brain—brain cancer	0.000231	0.0222	CbGeAlD
Meloxicam—Hypertension—Carmustine—brain cancer	0.000231	0.00175	CcSEcCtD
Meloxicam—Pain—Hydroxyurea—brain cancer	0.000231	0.00175	CcSEcCtD
Meloxicam—Constipation—Hydroxyurea—brain cancer	0.000231	0.00175	CcSEcCtD
Meloxicam—Dizziness—Procarbazine—brain cancer	0.00023	0.00175	CcSEcCtD
Meloxicam—ABCC4—endocrine gland—brain cancer	0.00023	0.0221	CbGeAlD
Meloxicam—PGD—Carbohydrate metabolism—ENO2—brain cancer	0.000229	0.0117	CbGpPWpGaD
Meloxicam—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000228	0.0116	CbGpPWpGaD
Meloxicam—Palpitations—Temozolomide—brain cancer	0.000228	0.00173	CcSEcCtD
Meloxicam—Myalgia—Carmustine—brain cancer	0.000227	0.00173	CcSEcCtD
Meloxicam—ABCC4—head—brain cancer	0.000227	0.0218	CbGeAlD
Meloxicam—Anxiety—Carmustine—brain cancer	0.000227	0.00172	CcSEcCtD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000225	0.0115	CbGpPWpGaD
Meloxicam—Cough—Temozolomide—brain cancer	0.000225	0.00171	CcSEcCtD
Meloxicam—Erythema multiforme—Etoposide—brain cancer	0.000224	0.00171	CcSEcCtD
Meloxicam—Convulsion—Temozolomide—brain cancer	0.000224	0.0017	CcSEcCtD
Meloxicam—Hypertension—Temozolomide—brain cancer	0.000223	0.00169	CcSEcCtD
Meloxicam—Feeling abnormal—Hydroxyurea—brain cancer	0.000222	0.00169	CcSEcCtD
Meloxicam—Eye disorder—Etoposide—brain cancer	0.000222	0.00169	CcSEcCtD
Meloxicam—Vomiting—Procarbazine—brain cancer	0.000222	0.00168	CcSEcCtD
Meloxicam—Flushing—Etoposide—brain cancer	0.00022	0.00167	CcSEcCtD
Meloxicam—Cardiac disorder—Etoposide—brain cancer	0.00022	0.00167	CcSEcCtD
Meloxicam—Confusional state—Carmustine—brain cancer	0.00022	0.00167	CcSEcCtD
Meloxicam—Arthralgia—Temozolomide—brain cancer	0.00022	0.00167	CcSEcCtD
Meloxicam—Myalgia—Temozolomide—brain cancer	0.00022	0.00167	CcSEcCtD
Meloxicam—Rash—Procarbazine—brain cancer	0.00022	0.00167	CcSEcCtD
Meloxicam—Dermatitis—Procarbazine—brain cancer	0.00022	0.00167	CcSEcCtD
Meloxicam—Anxiety—Temozolomide—brain cancer	0.000219	0.00166	CcSEcCtD
Meloxicam—Headache—Procarbazine—brain cancer	0.000218	0.00166	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000218	0.00166	CcSEcCtD
Meloxicam—Oedema—Carmustine—brain cancer	0.000218	0.00166	CcSEcCtD
Meloxicam—Discomfort—Temozolomide—brain cancer	0.000217	0.00165	CcSEcCtD
Meloxicam—Infection—Carmustine—brain cancer	0.000217	0.00165	CcSEcCtD
Meloxicam—Angiopathy—Etoposide—brain cancer	0.000215	0.00164	CcSEcCtD
Meloxicam—CYP2C8—pituitary gland—brain cancer	0.000215	0.0207	CbGeAlD
Meloxicam—Dry mouth—Temozolomide—brain cancer	0.000215	0.00163	CcSEcCtD
Meloxicam—PTGS1—telencephalon—brain cancer	0.000214	0.0206	CbGeAlD
Meloxicam—Immune system disorder—Etoposide—brain cancer	0.000214	0.00163	CcSEcCtD
Meloxicam—Mediastinal disorder—Etoposide—brain cancer	0.000214	0.00163	CcSEcCtD
Meloxicam—Thrombocytopenia—Carmustine—brain cancer	0.000214	0.00162	CcSEcCtD
Meloxicam—Body temperature increased—Hydroxyurea—brain cancer	0.000213	0.00162	CcSEcCtD
Meloxicam—Tachycardia—Carmustine—brain cancer	0.000213	0.00162	CcSEcCtD
Meloxicam—Confusional state—Temozolomide—brain cancer	0.000212	0.00161	CcSEcCtD
Meloxicam—Anaphylactic shock—Temozolomide—brain cancer	0.000211	0.0016	CcSEcCtD
Meloxicam—Oedema—Temozolomide—brain cancer	0.000211	0.0016	CcSEcCtD
Meloxicam—Alopecia—Etoposide—brain cancer	0.00021	0.00159	CcSEcCtD
Meloxicam—Infection—Temozolomide—brain cancer	0.000209	0.00159	CcSEcCtD
Meloxicam—ABCC4—central nervous system—brain cancer	0.000207	0.0199	CbGeAlD
Meloxicam—Nausea—Procarbazine—brain cancer	0.000207	0.00157	CcSEcCtD
Meloxicam—Nervous system disorder—Temozolomide—brain cancer	0.000207	0.00157	CcSEcCtD
Meloxicam—Thrombocytopenia—Temozolomide—brain cancer	0.000206	0.00157	CcSEcCtD
Meloxicam—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000205	0.0105	CbGpPWpGaD
Meloxicam—PTGS2—telencephalon—brain cancer	0.000205	0.0197	CbGeAlD
Meloxicam—Skin disorder—Temozolomide—brain cancer	0.000205	0.00156	CcSEcCtD
Meloxicam—Hypotension—Carmustine—brain cancer	0.000204	0.00155	CcSEcCtD
Meloxicam—Hyperhidrosis—Temozolomide—brain cancer	0.000204	0.00155	CcSEcCtD
Meloxicam—Dysgeusia—Etoposide—brain cancer	0.000202	0.00154	CcSEcCtD
Meloxicam—Back pain—Etoposide—brain cancer	0.0002	0.00152	CcSEcCtD
Meloxicam—Hypersensitivity—Hydroxyurea—brain cancer	0.000199	0.00151	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Carmustine—brain cancer	0.000199	0.00151	CcSEcCtD
Meloxicam—Muscle spasms—Etoposide—brain cancer	0.000199	0.00151	CcSEcCtD
Meloxicam—Insomnia—Carmustine—brain cancer	0.000197	0.0015	CcSEcCtD
Meloxicam—Paraesthesia—Carmustine—brain cancer	0.000196	0.00149	CcSEcCtD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000196	0.00997	CbGpPWpGaD
Meloxicam—Dyspnoea—Carmustine—brain cancer	0.000194	0.00148	CcSEcCtD
Meloxicam—Somnolence—Carmustine—brain cancer	0.000194	0.00147	CcSEcCtD
Meloxicam—Asthenia—Hydroxyurea—brain cancer	0.000194	0.00147	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000192	0.00146	CcSEcCtD
Meloxicam—Ill-defined disorder—Etoposide—brain cancer	0.000192	0.00146	CcSEcCtD
Meloxicam—Anaemia—Etoposide—brain cancer	0.000191	0.00145	CcSEcCtD
Meloxicam—Insomnia—Temozolomide—brain cancer	0.000191	0.00145	CcSEcCtD
Meloxicam—Decreased appetite—Carmustine—brain cancer	0.00019	0.00144	CcSEcCtD
Meloxicam—Paraesthesia—Temozolomide—brain cancer	0.000189	0.00144	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Carmustine—brain cancer	0.000188	0.00143	CcSEcCtD
Meloxicam—Dyspnoea—Temozolomide—brain cancer	0.000188	0.00143	CcSEcCtD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000188	0.00956	CbGpPWpGaD
Meloxicam—Somnolence—Temozolomide—brain cancer	0.000187	0.00142	CcSEcCtD
Meloxicam—Constipation—Carmustine—brain cancer	0.000186	0.00142	CcSEcCtD
Meloxicam—Pain—Carmustine—brain cancer	0.000186	0.00142	CcSEcCtD
Meloxicam—Malaise—Etoposide—brain cancer	0.000186	0.00142	CcSEcCtD
Meloxicam—Vertigo—Etoposide—brain cancer	0.000186	0.00141	CcSEcCtD
Meloxicam—Dyspepsia—Temozolomide—brain cancer	0.000185	0.00141	CcSEcCtD
Meloxicam—Leukopenia—Etoposide—brain cancer	0.000185	0.00141	CcSEcCtD
Meloxicam—Diarrhoea—Hydroxyurea—brain cancer	0.000185	0.0014	CcSEcCtD
Meloxicam—Decreased appetite—Temozolomide—brain cancer	0.000183	0.00139	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Temozolomide—brain cancer	0.000182	0.00138	CcSEcCtD
Meloxicam—Fatigue—Temozolomide—brain cancer	0.000182	0.00138	CcSEcCtD
Meloxicam—Loss of consciousness—Etoposide—brain cancer	0.000182	0.00138	CcSEcCtD
Meloxicam—Cough—Etoposide—brain cancer	0.00018	0.00137	CcSEcCtD
Meloxicam—Pain—Temozolomide—brain cancer	0.00018	0.00137	CcSEcCtD
Meloxicam—Constipation—Temozolomide—brain cancer	0.00018	0.00137	CcSEcCtD
Meloxicam—Feeling abnormal—Carmustine—brain cancer	0.00018	0.00137	CcSEcCtD
Meloxicam—Convulsion—Etoposide—brain cancer	0.000179	0.00136	CcSEcCtD
Meloxicam—Hypertension—Etoposide—brain cancer	0.000178	0.00136	CcSEcCtD
Meloxicam—Dizziness—Hydroxyurea—brain cancer	0.000178	0.00136	CcSEcCtD
Meloxicam—Gastrointestinal pain—Carmustine—brain cancer	0.000178	0.00136	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000175	0.00133	CcSEcCtD
Meloxicam—PTGS1—pituitary gland—brain cancer	0.000175	0.0168	CbGeAlD
Meloxicam—Discomfort—Etoposide—brain cancer	0.000174	0.00132	CcSEcCtD
Meloxicam—Feeling abnormal—Temozolomide—brain cancer	0.000174	0.00132	CcSEcCtD
Meloxicam—Abdominal pain—Carmustine—brain cancer	0.000172	0.00131	CcSEcCtD
Meloxicam—Body temperature increased—Carmustine—brain cancer	0.000172	0.00131	CcSEcCtD
Meloxicam—Gastrointestinal pain—Temozolomide—brain cancer	0.000172	0.00131	CcSEcCtD
Meloxicam—Vomiting—Hydroxyurea—brain cancer	0.000172	0.0013	CcSEcCtD
Meloxicam—Rash—Hydroxyurea—brain cancer	0.00017	0.00129	CcSEcCtD
Meloxicam—Confusional state—Etoposide—brain cancer	0.00017	0.00129	CcSEcCtD
Meloxicam—Dermatitis—Hydroxyurea—brain cancer	0.00017	0.00129	CcSEcCtD
Meloxicam—Headache—Hydroxyurea—brain cancer	0.000169	0.00128	CcSEcCtD
Meloxicam—Anaphylactic shock—Etoposide—brain cancer	0.000169	0.00128	CcSEcCtD
Meloxicam—Infection—Etoposide—brain cancer	0.000168	0.00127	CcSEcCtD
Meloxicam—Urticaria—Temozolomide—brain cancer	0.000167	0.00127	CcSEcCtD
Meloxicam—PTGS2—pituitary gland—brain cancer	0.000167	0.016	CbGeAlD
Meloxicam—CYP2C8—endocrine gland—brain cancer	0.000167	0.016	CbGeAlD
Meloxicam—Abdominal pain—Temozolomide—brain cancer	0.000167	0.00127	CcSEcCtD
Meloxicam—Body temperature increased—Temozolomide—brain cancer	0.000167	0.00127	CcSEcCtD
Meloxicam—PGD—Disease—DTX2—brain cancer	0.000166	0.00848	CbGpPWpGaD
Meloxicam—Thrombocytopenia—Etoposide—brain cancer	0.000165	0.00125	CcSEcCtD
Meloxicam—Tachycardia—Etoposide—brain cancer	0.000165	0.00125	CcSEcCtD
Meloxicam—ABCC4—brain—brain cancer	0.000164	0.0158	CbGeAlD
Meloxicam—Skin disorder—Etoposide—brain cancer	0.000164	0.00124	CcSEcCtD
Meloxicam—Hyperhidrosis—Etoposide—brain cancer	0.000163	0.00124	CcSEcCtD
Meloxicam—PTGS2—medulla oblongata—brain cancer	0.000161	0.0155	CbGeAlD
Meloxicam—Hypersensitivity—Carmustine—brain cancer	0.000161	0.00122	CcSEcCtD
Meloxicam—Nausea—Hydroxyurea—brain cancer	0.00016	0.00122	CcSEcCtD
Meloxicam—Hypotension—Etoposide—brain cancer	0.000158	0.0012	CcSEcCtD
Meloxicam—Asthenia—Carmustine—brain cancer	0.000156	0.00119	CcSEcCtD
Meloxicam—Hypersensitivity—Temozolomide—brain cancer	0.000155	0.00118	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000154	0.00786	CbGpPWpGaD
Meloxicam—Paraesthesia—Etoposide—brain cancer	0.000151	0.00115	CcSEcCtD
Meloxicam—Asthenia—Temozolomide—brain cancer	0.000151	0.00115	CcSEcCtD
Meloxicam—ABCC4—Ectoderm Differentiation—SHH—brain cancer	0.000151	0.00769	CbGpPWpGaD
Meloxicam—Dyspnoea—Etoposide—brain cancer	0.00015	0.00114	CcSEcCtD
Meloxicam—PTGS1—spinal cord—brain cancer	0.00015	0.0144	CbGeAlD
Meloxicam—Somnolence—Etoposide—brain cancer	0.00015	0.00114	CcSEcCtD
Meloxicam—Diarrhoea—Carmustine—brain cancer	0.000149	0.00113	CcSEcCtD
Meloxicam—Pruritus—Temozolomide—brain cancer	0.000149	0.00113	CcSEcCtD
Meloxicam—CYP2C9—endocrine gland—brain cancer	0.000148	0.0142	CbGeAlD
Meloxicam—PTGS2—midbrain—brain cancer	0.000147	0.0141	CbGeAlD
Meloxicam—Decreased appetite—Etoposide—brain cancer	0.000147	0.00111	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Etoposide—brain cancer	0.000146	0.00111	CcSEcCtD
Meloxicam—Fatigue—Etoposide—brain cancer	0.000145	0.0011	CcSEcCtD
Meloxicam—Dizziness—Carmustine—brain cancer	0.000144	0.0011	CcSEcCtD
Meloxicam—Constipation—Etoposide—brain cancer	0.000144	0.0011	CcSEcCtD
Meloxicam—Pain—Etoposide—brain cancer	0.000144	0.0011	CcSEcCtD
Meloxicam—Diarrhoea—Temozolomide—brain cancer	0.000144	0.0011	CcSEcCtD
Meloxicam—PTGS2—spinal cord—brain cancer	0.000144	0.0138	CbGeAlD
Meloxicam—Dizziness—Temozolomide—brain cancer	0.000139	0.00106	CcSEcCtD
Meloxicam—Feeling abnormal—Etoposide—brain cancer	0.000139	0.00106	CcSEcCtD
Meloxicam—Vomiting—Carmustine—brain cancer	0.000139	0.00105	CcSEcCtD
Meloxicam—Gastrointestinal pain—Etoposide—brain cancer	0.000138	0.00105	CcSEcCtD
Meloxicam—Rash—Carmustine—brain cancer	0.000137	0.00104	CcSEcCtD
Meloxicam—Dermatitis—Carmustine—brain cancer	0.000137	0.00104	CcSEcCtD
Meloxicam—Headache—Carmustine—brain cancer	0.000137	0.00104	CcSEcCtD
Meloxicam—PTGS1—endocrine gland—brain cancer	0.000135	0.013	CbGeAlD
Meloxicam—Vomiting—Temozolomide—brain cancer	0.000134	0.00102	CcSEcCtD
Meloxicam—Urticaria—Etoposide—brain cancer	0.000134	0.00102	CcSEcCtD
Meloxicam—PTGS1—head—brain cancer	0.000134	0.0128	CbGeAlD
Meloxicam—Abdominal pain—Etoposide—brain cancer	0.000133	0.00101	CcSEcCtD
Meloxicam—Body temperature increased—Etoposide—brain cancer	0.000133	0.00101	CcSEcCtD
Meloxicam—Rash—Temozolomide—brain cancer	0.000133	0.00101	CcSEcCtD
Meloxicam—Dermatitis—Temozolomide—brain cancer	0.000133	0.00101	CcSEcCtD
Meloxicam—Headache—Temozolomide—brain cancer	0.000132	0.001	CcSEcCtD
Meloxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.00013	0.00662	CbGpPWpGaD
Meloxicam—Nausea—Carmustine—brain cancer	0.00013	0.000984	CcSEcCtD
Meloxicam—PTGS2—endocrine gland—brain cancer	0.000129	0.0124	CbGeAlD
Meloxicam—PTGS2—head—brain cancer	0.000128	0.0123	CbGeAlD
Meloxicam—Nausea—Temozolomide—brain cancer	0.000125	0.000951	CcSEcCtD
Meloxicam—Hypersensitivity—Etoposide—brain cancer	0.000124	0.000944	CcSEcCtD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000124	0.00633	CbGpPWpGaD
Meloxicam—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000123	0.00625	CbGpPWpGaD
Meloxicam—PGD—Disease—HES5—brain cancer	0.000122	0.00622	CbGpPWpGaD
Meloxicam—PTGS1—central nervous system—brain cancer	0.000122	0.0117	CbGeAlD
Meloxicam—PTGS2—Spinal Cord Injury—GFAP—brain cancer	0.000121	0.00617	CbGpPWpGaD
Meloxicam—Asthenia—Etoposide—brain cancer	0.000121	0.000919	CcSEcCtD
Meloxicam—CYP2C8—brain—brain cancer	0.000119	0.0115	CbGeAlD
Meloxicam—Pruritus—Etoposide—brain cancer	0.000119	0.000907	CcSEcCtD
Meloxicam—PTGS2—central nervous system—brain cancer	0.000117	0.0112	CbGeAlD
Meloxicam—ABCC4—Hemostasis—MPL—brain cancer	0.000116	0.00593	CbGpPWpGaD
Meloxicam—Diarrhoea—Etoposide—brain cancer	0.000115	0.000877	CcSEcCtD
Meloxicam—PTGS2—cerebellum—brain cancer	0.000114	0.0109	CbGeAlD
Meloxicam—PTGS2—S1P1 pathway—VEGFA—brain cancer	0.000113	0.00577	CbGpPWpGaD
Meloxicam—CYP3A4—endocrine gland—brain cancer	0.000113	0.0108	CbGeAlD
Meloxicam—Dizziness—Etoposide—brain cancer	0.000112	0.000847	CcSEcCtD
Meloxicam—ABCC4—Hemostasis—S100A10—brain cancer	0.000111	0.00568	CbGpPWpGaD
Meloxicam—Vomiting—Etoposide—brain cancer	0.000107	0.000815	CcSEcCtD
Meloxicam—Rash—Etoposide—brain cancer	0.000106	0.000808	CcSEcCtD
Meloxicam—Dermatitis—Etoposide—brain cancer	0.000106	0.000807	CcSEcCtD
Meloxicam—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	0.000106	0.00541	CbGpPWpGaD
Meloxicam—Headache—Etoposide—brain cancer	0.000106	0.000803	CcSEcCtD
Meloxicam—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000105	0.00538	CbGpPWpGaD
Meloxicam—CYP3A4—central nervous system—brain cancer	0.000102	0.00978	CbGeAlD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000101	0.00513	CbGpPWpGaD
Meloxicam—Nausea—Etoposide—brain cancer	0.0001	0.000761	CcSEcCtD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—TRPC6—brain cancer	9.98e-05	0.00509	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—CYP2C9—brain cancer	9.96e-05	0.00508	CbGpPWpGaD
Meloxicam—ABCC4—Fluoropyrimidine Activity—TP53—brain cancer	9.82e-05	0.00501	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	9.82e-05	0.00501	CbGpPWpGaD
Meloxicam—PTGS1—brain—brain cancer	9.68e-05	0.00929	CbGeAlD
Meloxicam—ABCC4—Transmembrane transport of small molecules—S100A10—brain cancer	9.64e-05	0.00492	CbGpPWpGaD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	9.49e-05	0.00484	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	9.45e-05	0.00482	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CYP2C9—brain cancer	9.4e-05	0.00479	CbGpPWpGaD
Meloxicam—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	9.35e-05	0.00477	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	9.26e-05	0.00472	CbGpPWpGaD
Meloxicam—PTGS2—brain—brain cancer	9.25e-05	0.00888	CbGeAlD
Meloxicam—PGD—Disease—IDH1—brain cancer	8.21e-05	0.00419	CbGpPWpGaD
Meloxicam—PGD—Metabolism—BSG—brain cancer	7.99e-05	0.00408	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—BSG—brain cancer	7.85e-05	0.004	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—HES1—brain cancer	7.8e-05	0.00398	CbGpPWpGaD
Meloxicam—PGD—Disease—HEY1—brain cancer	7.78e-05	0.00397	CbGpPWpGaD
Meloxicam—PGD—Disease—DLL1—brain cancer	7.63e-05	0.00389	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	7.5e-05	0.00383	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—VAV1—brain cancer	7.48e-05	0.00381	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	7.28e-05	0.00371	CbGpPWpGaD
Meloxicam—PGD—Metabolism—IDH1—brain cancer	6.87e-05	0.00351	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	6.51e-05	0.00332	CbGpPWpGaD
Meloxicam—PGD—Disease—ENO2—brain cancer	6.49e-05	0.00331	CbGpPWpGaD
Meloxicam—PGD—Disease—SHH—brain cancer	6.49e-05	0.00331	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—VEGFA—brain cancer	6.4e-05	0.00327	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	6.17e-05	0.00315	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	6.14e-05	0.00313	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	6.1e-05	0.00311	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.92e-05	0.00302	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	5.58e-05	0.00284	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	5.46e-05	0.00278	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ENO2—brain cancer	5.43e-05	0.00277	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.35e-05	0.00273	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.27e-05	0.00269	CbGpPWpGaD
Meloxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	5.24e-05	0.00267	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	5.21e-05	0.00266	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TRPC6—brain cancer	5.14e-05	0.00262	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	5.13e-05	0.00262	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.02e-05	0.00256	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	4.75e-05	0.00242	CbGpPWpGaD
Meloxicam—ABCC4—Ectoderm Differentiation—CTNNB1—brain cancer	4.7e-05	0.0024	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.7e-05	0.0024	CbGpPWpGaD
Meloxicam—PGD—Disease—VAV1—brain cancer	4.69e-05	0.00239	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	4.68e-05	0.00238	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CDK4—brain cancer	4.66e-05	0.00238	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—TRPC6—brain cancer	4.45e-05	0.00227	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	4.33e-05	0.00221	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.33e-05	0.00221	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	4.28e-05	0.00218	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	4.19e-05	0.00214	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	4.14e-05	0.00211	CbGpPWpGaD
Meloxicam—PGD—Disease—HES1—brain cancer	4.03e-05	0.00206	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	3.95e-05	0.00201	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VAV1—brain cancer	3.85e-05	0.00197	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.85e-05	0.00196	CbGpPWpGaD
Meloxicam—PGD—Disease—PDGFRA—brain cancer	3.84e-05	0.00196	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.82e-05	0.00195	CbGpPWpGaD
Meloxicam—ABCC4—Ectoderm Differentiation—MYC—brain cancer	3.81e-05	0.00194	CbGpPWpGaD
Meloxicam—PTGS2—Disease—DTX2—brain cancer	3.7e-05	0.00189	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.67e-05	0.00187	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.44e-05	0.00175	CbGpPWpGaD
Meloxicam—PGD—Disease—IRS2—brain cancer	3.37e-05	0.00172	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	3.34e-05	0.0017	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.17e-05	0.00162	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—MYC—brain cancer	3.17e-05	0.00162	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL2—brain cancer	3.09e-05	0.00157	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CCND1—brain cancer	3.01e-05	0.00154	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.98e-05	0.00152	CbGpPWpGaD
Meloxicam—PGD—Disease—APC—brain cancer	2.98e-05	0.00152	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.84e-05	0.00145	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.8e-05	0.00143	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HES5—brain cancer	2.72e-05	0.00139	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP2C9—brain cancer	2.64e-05	0.00134	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CG—brain cancer	2.49e-05	0.00127	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CG—brain cancer	2.45e-05	0.00125	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MYC—brain cancer	2.41e-05	0.00123	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—EGFR—brain cancer	2.36e-05	0.0012	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.32e-05	0.00118	CbGpPWpGaD
Meloxicam—PGD—Disease—ERBB2—brain cancer	2.31e-05	0.00118	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.28e-05	0.00116	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—BSG—brain cancer	2.24e-05	0.00114	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP2C9—brain cancer	2.09e-05	0.00107	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.05e-05	0.00104	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.03e-05	0.00103	CbGpPWpGaD
Meloxicam—PGD—Disease—CTNNB1—brain cancer	2.02e-05	0.00103	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TP53—brain cancer	1.98e-05	0.00101	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—IDH1—brain cancer	1.93e-05	0.000983	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IDH1—brain cancer	1.83e-05	0.000932	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.78e-05	0.00091	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—BSG—brain cancer	1.78e-05	0.000908	CbGpPWpGaD
Meloxicam—PGD—Disease—STAT3—brain cancer	1.76e-05	0.000899	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HEY1—brain cancer	1.73e-05	0.000884	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IL2—brain cancer	1.72e-05	0.000878	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP2C9—brain cancer	1.7e-05	0.000869	CbGpPWpGaD
Meloxicam—PTGS2—Disease—DLL1—brain cancer	1.7e-05	0.000867	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.64e-05	0.000838	CbGpPWpGaD
Meloxicam—PGD—Disease—MYC—brain cancer	1.64e-05	0.000835	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.61e-05	0.000819	CbGpPWpGaD
Meloxicam—PGD—Disease—EGFR—brain cancer	1.6e-05	0.000817	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.57e-05	0.000801	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—IDH1—brain cancer	1.53e-05	0.000781	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ENO2—brain cancer	1.52e-05	0.000777	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—brain cancer	1.46e-05	0.000747	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—BSG—brain cancer	1.45e-05	0.000739	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ENO2—brain cancer	1.44e-05	0.000737	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SHH—brain cancer	1.44e-05	0.000737	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.35e-05	0.000688	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.25e-05	0.000636	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—IDH1—brain cancer	1.25e-05	0.000635	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ENO2—brain cancer	1.21e-05	0.000617	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—BSG—brain cancer	1.18e-05	0.000601	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—brain cancer	1.11e-05	0.000564	CbGpPWpGaD
Meloxicam—PTGS2—Disease—VAV1—brain cancer	1.04e-05	0.000532	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.01e-05	0.000517	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—IDH1—brain cancer	1.01e-05	0.000517	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ENO2—brain cancer	9.84e-06	0.000502	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP2C9—brain cancer	9.14e-06	0.000466	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HES1—brain cancer	8.98e-06	0.000458	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PDGFRA—brain cancer	8.55e-06	0.000436	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.25e-06	0.000421	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ENO2—brain cancer	8.01e-06	0.000409	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—BSG—brain cancer	7.77e-06	0.000396	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IRS2—brain cancer	7.5e-06	0.000383	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CG—brain cancer	6.99e-06	0.000357	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—IDH1—brain cancer	6.68e-06	0.000341	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APC—brain cancer	6.63e-06	0.000338	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CG—brain cancer	5.55e-06	0.000283	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ENO2—brain cancer	5.28e-06	0.00027	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERBB2—brain cancer	5.15e-06	0.000262	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CG—brain cancer	4.52e-06	0.00023	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CTNNB1—brain cancer	4.5e-06	0.00023	CbGpPWpGaD
Meloxicam—PTGS2—Disease—STAT3—brain cancer	3.92e-06	0.0002	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CG—brain cancer	3.68e-06	0.000187	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MYC—brain cancer	3.65e-06	0.000186	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGFR—brain cancer	3.57e-06	0.000182	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CG—brain cancer	2.42e-06	0.000124	CbGpPWpGaD
